AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

NEXT STORY
Trailblazing treatment by ChristianaCare physical therapists catches attention of NFL
PREV STORY
OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hua Medicine’s Pivotal Phase III Monotherapy Trial of Dorzagliatin, a Dual-Acting Glucokinase Modulator, Achieves Primary Efficacy Endpoint in Patients with Type 2 Diabetes

author_avatar
NASDAQ Market News

The global in-vitro diagnostics market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019

author_avatar
NASDAQ Market News

Quipt Announces Execution of LOI to Acquire Leader in Comprehensive Respiratory Care Within the Long-Term Care Setting With Approximately $14 Million in Annualized Revenue and $1 Million in Net Income

author_avatar
NASDAQ Market News